Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy.

Autores de IIS La Fe

• Joaquin Berenguer Lapuerta

  Autor

• Miguel Salavert Lletí

  Autor

• Tatiana Fernandez Portilla

  Autor

Participantes ajenos a IIS La Fe

• Alejos B
• Hernando V
• Viciana P
• Santos I
• Gómez-Sirvent JL
• Vidal F
• Del Amo J
• CoRIS (AIDS Research Network Cohort)

Grupos

• Infección Grave

Abstract

To study trends in overall deaths and cause-specific deaths stratified by hepatitis C virus (HCV) serostatus in a cohort of combination antiretroviral (cART)-naive HIV-infected patients in Spain.